Childs RW - Search Results

1

Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases.

Childs RW. Childs RW. Cancer J. 2000 May-Jun;6(3):179-87. Cancer J. 2000. PMID: 10882334 Clinical Trial. No abstract available.

2

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

Childs RW, Clave E, Tisdale J, Plante M, Hensel N, Barrett J. Childs RW, et al. J Clin Oncol. 1999 Jul;17(7):2044-9. doi: 10.1200/JCO.1999.17.7.2044. J Clin Oncol. 1999. PMID: 10561256

3

Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.

Childs RW. Childs RW. Crit Rev Immunol. 2001;21(1-3):191-203. Crit Rev Immunol. 2001. PMID: 11642604 Review.

4

The identification of renal cell carcinoma as a target for allogeneic based cancer immunotherapy.

Childs RW, Igarashi T. Childs RW, et al. Exp Nephrol. 2002;10(3):227-34. doi: 10.1159/000058349. Exp Nephrol. 2002. PMID: 12053124 Review.

5

Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation.

Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE. Hematti P, et al. Among authors: childs rw. Exp Hematol. 2002 Aug;30(8):943-9. doi: 10.1016/s0301-472x(02)00873-1. Exp Hematol. 2002. PMID: 12160846 Free article.

6

Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation.

Childs RW. Childs RW. MedGenMed. 2002 Jun 26;4(3):13. MedGenMed. 2002. PMID: 12466756 Free article. Review. No abstract available.

7

Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement.

Drachenberg D, Childs RW. Drachenberg D, et al. Among authors: childs rw. Urol Clin North Am. 2003 Aug;30(3):611-22. doi: 10.1016/s0094-0143(03)00025-9. Urol Clin North Am. 2003. PMID: 12953759 Review.

8

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.

Takahashi Y, McCoy JP Jr, Carvallo C, Rivera C, Igarashi T, Srinivasan R, Young NS, Childs RW. Takahashi Y, et al. Among authors: childs rw. Blood. 2004 Feb 15;103(4):1383-90. doi: 10.1182/blood-2003-04-1281. Epub 2003 Oct 2. Blood. 2004. PMID: 14525787 Free article. Clinical Trial.

9

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors.

Carvallo C, Geller N, Kurlander R, Srinivasan R, Mena O, Igarashi T, Griffith LM, Linehan WM, Childs RW. Carvallo C, et al. Among authors: childs rw. Blood. 2004 Feb 15;103(4):1560-3. doi: 10.1182/blood-2003-04-1170. Epub 2003 Oct 9. Blood. 2004. PMID: 14551148 Free article.

10

The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.

Sloand E, Childs RW, Solomon S, Greene A, Young NS, Barrett AJ. Sloand E, et al. Among authors: childs rw. Bone Marrow Transplant. 2003 Nov;32(9):897-901. doi: 10.1038/sj.bmt.1704231. Bone Marrow Transplant. 2003. PMID: 14561990 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters